Table 2.
Source of data and characteristics of studies used to develop models for pregnancy complications in women with gestational diabetes.
| Model | Source of Data | Study Setting | Study Dates | Sample Size | |
|---|---|---|---|---|---|
| A risk engine relating maternal glycaemia and body mass index to pregnancy outcomes [21] | Prospective cohort (post hoc analysis) | Single centre The antenatal clinic, Mater Misericordiae Mothers’ Hospital, Australia |
Jul 2000– Apr 2006 |
n = 1248 | |
| Screening tool for predicting adverse outcomes of GDM [22] | Retrospective cohort | Single centre Admitted patients, Severance Hospital, South Korea |
Mar 2001–Apr 2013 |
n = 802 (306 in GDM group) |
|
| A risk score based on clinical characteristics of GDM women for the development of preeclampsia [23] | Retrospective cohort | Single centre The antenatal clinic, Vajira Hospital, Thailand |
Jan 2003– Feb 2008 |
n = 813 | |
| Subgroups at different risks of developing the composite adverse neonatal outcome [24] | Retrospective cohort | Multi-centre Specialised GDM clinics, Various hospitals, Italy |
Jan 2012–May 2015 | n = 2736 | |
| The fetal overgrowth index [25] | Retrospective cohort | Single centre Collaborative diabetes in pregnancy program, South Shore Hospital, USA |
Mar 2010–May 2012 | n = 275 |
Abbreviation: GDM, gestational diabetes.